How medicine list prices are published across Europe: who publishes what, and which price it is

Why there is no single answer

Marketing authorisation is harmonised across the EU; pricing and reimbursement are not. Each member state sets, or declines to set, medicine prices under its own law, and publishes them under its own rules. The Transparency Directive obliges states to publish the prices and reimbursement decisions they make, which is why there is usually an official list, but it does not say what price, in what format, or how often. The result is thirty-odd lists that look alike and mean different things.

Before comparing two of them, settle which rung of the ladder each one shows.

The sources, country by country

The table covers the markets most relevant to parallel trade and European launch planning. “Price type” is the main published rung; many lists carry more than one. Access: public means free to anyone; commercial means the authoritative list is sold by a publisher and the state’s own publication is partial or absent.

Countries not listed (Bulgaria, Croatia, Slovenia, Cyprus, Malta) publish positive or reimbursement lists through their health insurance funds or ministries; the country guides cover each.

What the differences mean in practice

Price type first. Comparing a French PFHT with a German AVP compares a manufacturer price with a retail price including margins and VAT. Comparing a UK Drug Tariff price with anything compares a reimbursement price, which for generics is set by a survey of actual purchase prices and bears no fixed relation to any list price.

Cadence second. Danish prices can change every two weeks and Dutch and German lists monthly or fortnightly, while some Southern and Eastern European lists update when the ministry publishes. A comparison is a snapshot with dates on it.

Scope third. Most lists cover reimbursed products only. Non-reimbursed and hospital-only products are often missing or priced differently (hospital prices in several countries are tendered and not published at all).

Currency and VAT last. Convert at a stated rate, and strip VAT to compare ex-factory or wholesale levels.

What this means for traders, planners and buyers

For parallel traders, the published list is the starting point for the differential, not the differential: the price that matters is the one at which product can actually be bought in the exporting country, after discounts and in the pack size the destination accepts. For launch planners, the lists tell you what the reimbursed price of the originator is in each market and, where reference-price groups exist, what the generic will be allowed. For buyers, the lists are the benchmark for what you are being charged.

MPA collects the official lists for the markets it covers, aligns the price types, and keeps the history; the prices dataset in MPA Search is that work, with the source reference on every record.